Inve US ▾
ELELMT

Elmet Group (ELMT) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Industrials· Aug 13, 2026

Source: earnings call transcript

Executive summary

Elmet Group Q2 FY26 — Record Backlog and Strong Profitability Driven by Strategic Sourcing

Elmet Group delivered a strong second quarter, marked by significant revenue and adjusted EBITDA growth, alongside a record backlog, primarily fueled by strategic tungsten sourcing and robust demand in the aerospace, defense, and government (ADG) sector. The company continues to leverage its unique position as a U.S.-based critical materials supplier, investing in capacity expansion and navigating dynamic metals markets. While IPO-related expenses impacted GAAP net income, management remains confident in long-term margin expansion and growth opportunities, particularly within ADG and industrial end markets.

Highlights

5
  • Revenue increased 35% year-over-year to $66.4 million.

  • Gross profit expanded by 430 basis points to 25% gross margin.

  • Adjusted EBITDA grew 57.9% to $8.9 million.

  • Open order backlog reached a record $131.5 million, up 55% year-over-year.

  • ADG end market backlog increased 100.5% year-over-year, driven by new programs.

Concerns

4
  • Operating expenses increased 251.2% to $24.2 million, primarily due to $14.2 million in equity-based compensation related to the IPO.

  • Net loss for Q2 FY26 was $4.5 million, or $0.16 per share, compared to net income of $1.2 million in Q2 FY25.

  • EMP division experienced operational challenges in Q2, impacting higher-margin ADG and semiconductor product lines.

  • Backlog outside of ADG declined, primarily due to inconsistent order patterns from a large medical customer.

Guidance & targets

CategoryTargetConfidence
Adjusted Gross Margin
30%
high materiality
High

Segment performance

SegmentRevenueYoYQoQMargin
Critical Materials Components (CMC)
The CMC division was the primary driver of the overall gross profit increase, benefiting from strategic tungsten sourcing that allowed the company to capture gains from sharp price increases and favorable impacts from productivity improvements across its sites. The medical end market within CMC experienced a significant decline in backlog due to inconsistent ordering patterns from a large customer.
Gross margin increase driven by strategic tungsten sourcing agreements and productivity increasesMedical backlog: $5.5 million in Q2 2026 vs $12 million in Q2 2025
————

Orderbook & backlog

Firm order backlog $131.5 million Q2 FY26 end

up 55% YoY; up from $113.3 million in Q1 FY26 and $84.6 million in Q2 FY25

ADG end market backlog up 100.5% Q2 FY26 end

YoY

Driven by new and growing programs such as CERN, Strategic Missile Systems, PrSM, Standard Missile, and Patriot, along with commercial and defense-related aerospace and radar programs.

Deals & partnerships

EQ Resources Increased ownership stake and long-term offtake contract long-term

Increased ownership stake in EQ Resources as part of a strategic collaboration and long-term offtake contract, aimed at securing sustainable and resilient supply chain for critical raw materials, particularly tungsten.

Risks & headwinds

Significant and persistent rise in tungsten and molybdenum prices past year

dramatically increased over the last year

Mitigation:Sourcing >95% of materials from outside China for over a decade; strategic tungsten sourcing agreements.

Fluctuating and steep tariffs on critical materials ongoing

fluctuating and often steep tariffs

Mitigation:Strategic sourcing and operational agility to navigate market dynamics.

Operational challenges in EMP division Q2 FY26, expected to take a while to correct in H2

operational challenges in Q2

Mitigation:Working diligently to correct issues in the second half of the year.

Inconsistent order patterns from large medical customer Q2 FY26

medical backlog down from $12 million in Q2 FY25 to $5.5 million in Q2 FY26

Mitigation:Acknowledged as a source of volatility; actual demand is up, but ordering behavior is inconsistent.

What to watch in Q3 FY26

Flow-down of large defense prime awards

Next quarter / coming quarters
Current Not yet reflected in backlog
Target Significant new appropriation cycle funding in backlog

Why it matters

These awards represent substantial future revenue and growth opportunities for the ADG segment.

But nothing from the new appropriation cycle is really in our backlog at this point in time of significance.

Find out whether ELMT delivers this. Inve re-checks your case every morning.

Q&A highlights

Are recent large missile defense interceptor awards to defense primes reflected in Elmet's backlog, and what is the timing for these potential orders?

Management confirmed that significant new appropriation cycle funding from large multi-year prime awards has not yet flowed down to Elmet's backlog. They have seen some RFQ activity and modest 'sweep funding' orders for spares or small multi-year quantities, but nothing substantial from the new cycle.

“But nothing from the new appropriation cycle is really in our backlog at this point in time of significance.”

asked by Colin Canfield · answered by Michael Lee

2 min read 6 chapters

Detailed narrative

Strategic Positioning and Market Tailwinds

Elmet Group highlighted its unique position as the sole U.S.-based provider of certain precision engineered refractory metal components and high-power microwave systems. The company benefits from macro tailwinds such as defense fortification, U.S. reshoring, and a focus on material independence, which are driving backlog and future growth. Its vertically integrated operations and difficult-to-replicate asset base create high barriers to entry, supporting a strong long-term outlook.

Impact of Tungsten and Molybdenum Pricing

The significant rise in tungsten and molybdenum prices, exacerbated by export controls, has been a major factor impacting results. Elmet's strategy of sourcing over 95% of these materials from outside China for over a decade, combined with strategic sourcing agreements, has largely shielded it from supply chain disruptions and allowed it to capture benefits from price increases.

This dynamic drove a portion of the Q2 backlog increase and contributed to gross margin expansion.

Investments in Growth and Capacity

To support accelerating demand, Elmet is investing in growth, including significant increases in staffing and third-party support for its Critical Materials Components (CMC) factories, which are already yielding favorable productivity impacts. The company secured $4.3 million in strategic funding to develop and advance domestic manufacturing capabilities for molybdenum-based products used in critical defense programs, aiming to expand capacity and deploy advanced manufacturing technologies.

ADG Market Strength and Program Contributions

The Aerospace, Defense, and Government (ADG) end market backlog was up 100.5% year-over-year, driven by new and growing programs such as CERN, Strategic Missile Systems, PrSM, Standard Missile, and Patriot. Management noted that while large multi-year awards to primes haven't fully flowed down yet, they anticipate continued funding opportunities from the ongoing budget and appropriation cycle, expecting ADG to drive long-term growth at higher margins.

Medical Customer Volatility and Other End Markets

The decline in backlog outside of ADG was primarily attributed to the inconsistent order patterns of a large medical customer, which creates volatility in the 'other' segment. While actual demand from this customer is up year-over-year, their ordering behavior impacts quarterly backlog.

Other end markets like industrial and semiconductor are showing traction, with industrial seeing an uptick in both CMC and EMP divisions, and energy demand awaiting fusion and vision development cycles.

EMP Division Operational Challenges

The EMP division experienced operational challenges in Q2, particularly in the factory dealing with higher-margin ADG and semiconductor products. This impacted EMP's EBITDA margins. Management is diligently working to correct these issues in the second half of the year, expecting some improvement but acknowledging it will take time to fully resolve.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.